ORASEPTIC PASTILLE ANTISEP 1.5MG CITRON 1.5 MG
DOMIPHEN BROMIDE : 1.5 MG · DIN 01942883 · PRODEMDIS ENR.
Health Canada status: CANCELLED POST MARKET
What is ORASEPTIC PASTILLE ANTISEP 1.5MG CITRON?
ORASEPTIC PASTILLE ANTISEP 1.5MG CITRON 1.5 MG contains DOMIPHEN BROMIDE : 1.5 MG. It is listed in the Health Canada Drug Product Database under DIN 01942883, held by PRODEMDIS ENR., supplied as LOZENGE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 03-Aug-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01942883 |
|---|---|
| Brand name | ORASEPTIC PASTILLE ANTISEP 1.5MG CITRON |
| Generic / active ingredient | DOMIPHEN BROMIDE : 1.5 MG |
| Manufacturer | PRODEMDIS ENR. |
| Strength | 1.5 MG |
| Dosage form | LOZENGE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A01AB06 DOMIPHEN |
| AHFS class | 52:04.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 03-Aug-2000 |
| Original market date | 1991-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A01AB06 DOMIPHEN. 0 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ANTISEPTIQUE PASTILLE 1.5MG CERISE | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00873519 |
| ANTISEPTIQUE PASTILLE 1.5MG CITRON | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00873551 |
| ANTISEPTIQUE PASTILLE 1.5MG MENTHE | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00873527 |
| ANTISEPTIQUE PASTILLE 1.5MG MIEL EUCALYPTUS | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00873535 |
| BRONCHODEX PASTILLE 1.5MG MIEL EUC | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00846511 |
| BRONCHODEX PASTILLES 1.5MG SAVEUR CERISE | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00616168 |
| BRONCHODEX PASTILLES 1.5MG SAVEUR CITRON | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00616141 |
| BRONCHODEX PASTILLES 1.5MG SAVEUR MENTHE | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00616133 |
| ORA-SEPTIC CERISES LOZ 1.5MG | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00793388 |
| ORASEPTIC PASTILLE ANTISEP 1.5MG MENTHE | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 01942891 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.